Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 19, 2007

CellCyte Forms Device Division for Stem Cell Cultivation and Replication Products

  • CellCyte Genetics formed a new device division to develop, manufacture, and market its patented line of stem cell cultivation and replication devices. The company reports that it is designing stem cell enabling therapeutic products that allow more efficient delivery and increased retention of adult stem cells to diseased organs.

    Along with its planned human trials for its therapeutics, CellCyte Genetics intends to develop a new stem cell cultivation device, or bioreactor unit. The company plans to market the device for applications that will require cells to be grown under regulated oxygen concentrations, e.g. the replication of stem cells and the culture of pancreatic islet cells prior to transplantation into diabetic patients.

    “CellCyte’s patented biological cell maintenance system has the unique ability to incubate cultured cells with a very efficient and regulatable oxygen supply, making it an ideal choice for culturing cells that are otherwise difficult to keep alive or to expand,” explains Ron Berninger, CSO.

    “The cells can also form a 3-dimensional network inside the bioreactor, which is what most cell types do in major organs of the body.”

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »